Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
Qing Zhang, Yanmei Zhang, Lu Zeng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Chronic kidney disease and gut microbiota
Siamak Amini Khiabani, Mohammad Asgharzadeh, Hossein Samadi Kafil
Heliyon (2023) Vol. 9, Iss. 8, pp. e18991-e18991
Open Access | Times Cited: 29
Disentangling the Complexity of Nutrition, Frailty and Gut Microbial Pathways during Aging: A Focus on Hippuric Acid
Andrea Ticinesi, Angela Guerra, Antonio Nouvenne, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1138-1138
Open Access | Times Cited: 27
The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 24
Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”
Zhen Shen, Tao Cui, Yao Liu, et al.
Phytomedicine (2023) Vol. 121, pp. 155129-155129
Closed Access | Times Cited: 24
Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
Bo Zhang, Yuzhou Wan, Xuefeng Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
A look beyond dietary (poly)phenols: The low molecular weight phenolic metabolites and their concentrations in human circulation
Diogo Carregosa, Catarina Pinto, María Ángeles Ávila‐Gálvez, et al.
Comprehensive Reviews in Food Science and Food Safety (2022) Vol. 21, Iss. 5, pp. 3931-3962
Open Access | Times Cited: 35
Gut microbiota may modify the association between dietary polyphenol intake and circulating levels of hippuric acid: results from a 1-year longitudinal study in China
Yutong Pan, Yang Yang, Zhaohong Peng, et al.
American Journal of Clinical Nutrition (2025)
Closed Access
Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy
Ruijing Zhang, Runze Chang, Heng Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease
I‐Wen Wu, Yu-Chieh Liao, Tsung-Hsien Tsai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases
Qiulan Lv, Zhiyuan Li, Aihua Sui, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 22
Abnormal tryptophan catabolism in diabetes mellitus and its complications: Opportunities and challenges
Jialiang Gao, Ting Yang, Bohan Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115395-115395
Open Access | Times Cited: 12
Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
Dan‐Qian Chen, Jun Wu, Ping Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis
N. Stepanova
Kidney Medicine (2023) Vol. 5, Iss. 6, pp. 100645-100645
Open Access | Times Cited: 11
Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
Lavinia Balint, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1086-1086
Open Access | Times Cited: 11
Analysis of intestinal flora and cognitive function in maintenance hemodialysis patients using combined 16S ribosome DNA and shotgun metagenome sequencing
Qiuyi Gao, D. Li, Yue Wang, et al.
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 3
Recent advances of gut microbiota in chronic kidney disease patients
Ying‐Yong Zhao
Exploration of Medicine (2022), pp. 260-274
Open Access | Times Cited: 17
Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease
Rongping Chen, Dan Zhu, Rui Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 13, pp. 750-750
Open Access | Times Cited: 16
Big Data in Gastroenterology Research
Madeline Alizadeh, Natalia Sampaio Moura, Alyssa Schledwitz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2458-2458
Open Access | Times Cited: 9
Ameliorative effect of tuna elastin peptides on AIA mice by regulating the composition of intestinal microorganisms and SCFAs
Zhen Zhang, Haitao Wan, Jiaojiao Han, et al.
Journal of Functional Foods (2022) Vol. 92, pp. 105076-105076
Open Access | Times Cited: 15
Identifying the Novel Gut Microbial Metabolite Contributing to Metabolic Syndrome in Children Based on Integrative Analyses of Microbiome-Metabolome Signatures
Jia Wei, Wen Dai, Xiongfeng Pan, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
Causal relationship of gut microbiota with diabetic nephropathy: a Mendelian randomization analysis
Wei Yan, Ying Ge, Lina Wang, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Molecular Insights into the One-Carbon Loss Oxidation of Indole-3-acetic Acid
Jian Cheng, Nanxi Wang, Lu Yu, et al.
ACS Catalysis (2024) Vol. 14, Iss. 11, pp. 8528-8540
Closed Access | Times Cited: 2
Assessment of the relationship between gut microbiota and bone mineral density: a two-sample Mendelian randomization study
Yuan Xue, Xuan Wang, Honglin Liu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Guild-level signature of gut microbiome for diabetic kidney disease
Shasha Tang, Guojun Wu, Yalei Liu, et al.
mBio (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top